 | Up a level |
Tedesco-Silva, Helio; Pascual, Julio; Viklicky, Ondrej; Basic-Jukic, Nikolina; Cassuto, Elisabeth; Kim, Dean Y; Cruzado, Josep M; Sommerer, Claudia; Adel Bakr, Mohamed; Garcia, Valter D; Huynh-Do, Uyen; Russ, Graeme; Soo Kim, Myoung; Kuypers, Dirk; Buchler, Matthias; Citterio, Franco; Hernandez Gutierrez, Maria Pilar; Bernhardt, Peter; Chadban, Steve (2019). Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study. Transplantation, 103(9), pp. 1953-1963. Lippincott Williams & Wilkins 10.1097/TP.0000000000002626
Sommerer, Claudia; Duerr, Michael; Witzke, Oliver; Lehner, Frank; Arns, Wolfgang; Kliem, Volker; Ackermann, Daniel; Guba, Markus; Jacobi, Johannes; Hauser, Ingeborg A; Stahl, Rolf; Reinke, Petra; Rath, Thomas; Veit, Justyna; Mehrabi, Arianeb; Porstner, Martina; Budde, Klemens (2018). Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy. American journal of transplantation, 18(12), pp. 2965-2976. Wiley-Blackwell 10.1111/ajt.14897
Pascual, Julio; Berger, Stefan P; Witzke, Oliver; Tedesco, Helio; Mulgaonkar, Shamkant; Qazi, Yasir; Chadban, Steven; Oppenheimer, Federico; Sommerer, Claudia; Oberbauer, Rainer; Watarai, Yoshihiko; Legendre, Christophe; Citterio, Franco; Henry, Mitchell; Srinivas, Titte R; Luo, Wen-Lin; Marti, AnaMaria; Bernhardt, Peter; Vincenti, Flavio and TRANSFORM, Investigators (2018). Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation. Journal of the American Society of Nephrology : JASN, 29(7), pp. 1979-1991. American Society of Nephrology 10.1681/ASN.2018010009
Budde, Klemens; Becker, Thomas; Arns, Wolfgang; Sommerer, Claudia; Reinke, Petra; Eisenberger, Ute; Kramer, Stefan; Fischer, Wolfgang; Gschaidmeier, Harald; Pietruck, Frank; ZEUS Study Investigators, (2011). Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet, 377(9768), pp. 837-47. London: Elsevier 10.1016/S0140-6736(10)62318-5
